| Josephine Calina Rosales, OTR/L, SWC | |
|
3711 W 230th St Apt 135, Torrance, CA 90505-3823 | |
| (630) 890-9873 | |
| Not Available |
| Full Name | Josephine Calina Rosales |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3711 W 230th St Apt 135, Torrance, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053324939 | NPI | - | NPPES |
| Provider Name | Feld Care Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770069338 PECOS PAC ID: 6507101359 Enrollment ID: O20181222000200 |
News Archive
The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2021 class of Innovation Fund investigators.
A novel, targeted approach to chemotherapy that makes ovarian cancer cells more susceptible to the cytotoxic effects of an antitumor drug may offer a safer, more effective treatment option for this often deadly form of cancer.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
Researchers at the University of Montreal and its affiliated CHU Sainte-Justine and CHUM hospitals have linked some cases of Essential Tremor (ET) to a specific genetic problem. ET is the most common movement disorder, becoming increasingly frequent with increasing age, which is characterized by an involuntary shaking movement (tremor) that occurs with motion, particularly when doing precise fine movement.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josephine Calina Rosales, OTR/L, SWC 3711 W 230th St Apt 135, Torrance, CA 90505-3823 Ph: (630) 890-9873 | Josephine Calina Rosales, OTR/L, SWC 3711 W 230th St Apt 135, Torrance, CA 90505-3823 Ph: (630) 890-9873 |
News Archive
The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2021 class of Innovation Fund investigators.
A novel, targeted approach to chemotherapy that makes ovarian cancer cells more susceptible to the cytotoxic effects of an antitumor drug may offer a safer, more effective treatment option for this often deadly form of cancer.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
Researchers at the University of Montreal and its affiliated CHU Sainte-Justine and CHUM hospitals have linked some cases of Essential Tremor (ET) to a specific genetic problem. ET is the most common movement disorder, becoming increasingly frequent with increasing age, which is characterized by an involuntary shaking movement (tremor) that occurs with motion, particularly when doing precise fine movement.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
› Verified 8 days ago
Stephanie Hoffman, MA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19401 S Vermont Ave, Suite A-200, Torrance, CA 90502 Phone: 310-323-6887 | |
Valerie Rougeau, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1815 W. 213th Street, Suite 100, Torrance, CA 90501 Phone: 310-328-0693 Fax: 310-328-7058 | |
Mrs. Amanda Michelle Littlejohn, MS OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 310, Torrance, CA 90505 Phone: 310-370-1200 | |
Irene Shin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21515 Hawthorne Blvd Ste G100, Torrance, CA 90503 Phone: 424-571-2618 Fax: 424-571-2339 | |
Dana Granado, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19401 S Vermont Ave, Suite A-200, Torrance, CA 90502 Phone: 310-323-6887 | |
Ms. Kimberly Marie Ford, MA, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3475 Torrance Blvd, Suite B-2, Torrance, CA 90503 Phone: 310-316-7748 | |
Heather Hudgins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18512 Hawthorne Blvd, Torrance, CA 90504 Phone: 310-371-8555 Fax: 310-371-4488 |